This transiently impairs early stages of memory formation, which can be reversed by compounds that increase cholinergic tone such as the cholinesterase inhibitors used for the treatment of mild-to-moderate Alzheimer’s disease [52]. Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.